Cargando…
Molecular Analysis of 55 Spanish Patients with Acute Intermittent Porphyria
Acute intermittent porphyria (AIP) results from a decreased activity of hepatic hydroxymethylbilane synthase (HMBS), the third enzyme in the heme biosynthetic pathway. AIP is an autosomal dominant disorder with incomplete penetrance, characterized by acute neurovisceral attacks precipitated by sever...
Autores principales: | Morán-Jiménez, María-José, Borrero-Corte, María-José, Jara-Rubio, Fátima, García-Pastor, Inmaculada, Díaz-Díaz, Silvia, Castelbón-Fernandez, Francisco-Javier, Enríquez-de-Salamanca, Rafael, Méndez, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464722/ https://www.ncbi.nlm.nih.gov/pubmed/32806544 http://dx.doi.org/10.3390/genes11080924 |
Ejemplares similares
-
Acute intermittent porphyria, givosiran, and homocysteine
por: Fontanellas, Antonio, et al.
Publicado: (2021) -
High Prevalence of Insulin Resistance in Asymptomatic Patients with Acute Intermittent Porphyria and Liver-Targeted Insulin as a Novel Therapeutic Approach
por: Solares, Isabel, et al.
Publicado: (2021) -
Understanding Carbohydrate Metabolism and Insulin Resistance in Acute Intermittent Porphyria
por: Solares, Isabel, et al.
Publicado: (2022) -
Acute intermittent porphyria
por: Syal, Kartik, et al.
Publicado: (2015) -
Intermittent Acute Porphyria
por: Macleod, J. G., et al.
Publicado: (1953)